Precision Biosciences Stock Current Valuation

DTIL Stock  USD 12.98  0.23  1.80%   
Valuation analysis of Precision BioSciences helps investors to measure Precision BioSciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Multiple is expected to rise to -937.06 this year. Fundamental drivers impacting Precision BioSciences' valuation include:
Price Book
2.8796
Enterprise Value
-14.7 M
Enterprise Value Ebitda
0.1928
Price Sales
1.6006
Enterprise Value Revenue
0.0292
Overvalued
Today
12.98
Please note that Precision BioSciences' price fluctuation is relatively risky at this time. Calculation of the real value of Precision BioSciences is based on 3 months time horizon. Increasing Precision BioSciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Precision BioSciences is useful when determining the fair value of the Precision stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Precision BioSciences. Since Precision BioSciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Precision Stock. However, Precision BioSciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  12.98 Real  7.33 Target  3.07 Hype  12.89 Naive  15.01
The real value of Precision Stock, also known as its intrinsic value, is the underlying worth of Precision BioSciences Company, which is reflected in its stock price. It is based on Precision BioSciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Precision BioSciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Precision BioSciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
7.33
Real Value
13.76
Upside
Estimating the potential upside or downside of Precision BioSciences helps investors to forecast how Precision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Precision BioSciences more accurately as focusing exclusively on Precision BioSciences' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-3.24-0.11-1.29
Details
Hype
Prediction
LowEstimatedHigh
6.4612.8919.32
Details
Naive
Forecast
LowNext ValueHigh
8.5815.0121.44
Details
3 Analysts
Consensus
LowTarget PriceHigh
2.793.073.41
Details

Precision Current Valuation Analysis

Precision BioSciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Precision BioSciences Current Valuation

    
  (14.68 M)  
Most of Precision BioSciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precision BioSciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Precision Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Precision BioSciences is extremely important. It helps to project a fair market value of Precision Stock properly, considering its historical fundamentals such as Current Valuation. Since Precision BioSciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Precision BioSciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Precision BioSciences' interrelated accounts and indicators.
0.420.89-0.480.89-0.88-0.060.760.10.90.750.990.860.730.79-0.93-0.060.960.940.560.960.480.720.72-0.38
0.420.18-0.090.17-0.54-0.880.670.250.460.610.410.330.110.5-0.16-0.60.520.210.350.18-0.440.480.48-0.17
0.890.18-0.641.0-0.720.150.570.180.770.370.850.880.860.57-0.910.050.810.980.290.910.750.360.36-0.25
-0.48-0.09-0.64-0.640.60.12-0.57-0.7-0.65-0.04-0.34-0.68-0.9-0.540.510.04-0.57-0.65-0.25-0.44-0.44-0.08-0.080.42
0.890.171.0-0.64-0.720.150.570.170.770.370.850.880.850.56-0.910.050.810.980.290.910.750.360.36-0.24
-0.88-0.54-0.720.6-0.720.32-0.95-0.3-0.98-0.75-0.82-0.83-0.73-0.940.820.17-0.96-0.83-0.56-0.78-0.18-0.76-0.760.53
-0.06-0.880.150.120.150.32-0.5-0.4-0.24-0.35-0.040.00.04-0.36-0.160.74-0.220.11-0.240.190.62-0.27-0.270.21
0.760.670.57-0.570.57-0.95-0.50.280.930.720.690.760.60.91-0.67-0.270.880.690.60.63-0.060.70.7-0.6
0.10.250.18-0.70.17-0.3-0.40.280.23-0.05-0.030.30.60.230.03-0.150.280.18-0.06-0.070.03-0.08-0.080.06
0.90.460.77-0.650.77-0.98-0.240.930.230.720.850.840.750.95-0.87-0.120.950.870.640.840.280.750.75-0.65
0.750.610.37-0.040.37-0.75-0.350.72-0.050.720.780.470.250.8-0.57-0.190.780.510.730.63-0.120.970.97-0.43
0.990.410.85-0.340.85-0.82-0.040.69-0.030.850.780.780.620.76-0.91-0.050.910.90.590.960.470.770.77-0.38
0.860.330.88-0.680.88-0.830.00.760.30.840.470.780.850.67-0.820.170.880.920.360.830.450.430.43-0.3
0.730.110.86-0.90.85-0.730.040.60.60.750.250.620.850.6-0.740.060.770.870.240.70.630.260.26-0.26
0.790.50.57-0.540.56-0.94-0.360.910.230.950.80.760.670.6-0.75-0.170.870.70.740.710.090.860.86-0.74
-0.93-0.16-0.910.51-0.910.82-0.16-0.670.03-0.87-0.57-0.91-0.82-0.74-0.75-0.06-0.86-0.96-0.44-0.97-0.64-0.62-0.620.46
-0.06-0.60.050.040.050.170.74-0.27-0.15-0.12-0.19-0.050.170.06-0.17-0.06-0.140.06-0.080.110.31-0.12-0.120.03
0.960.520.81-0.570.81-0.96-0.220.880.280.950.780.910.880.770.87-0.86-0.140.90.570.870.30.750.75-0.41
0.940.210.98-0.650.98-0.830.110.690.180.870.510.90.920.870.7-0.960.060.90.410.950.660.510.51-0.35
0.560.350.29-0.250.29-0.56-0.240.6-0.060.640.730.590.360.240.74-0.44-0.080.570.410.52-0.040.760.76-0.8
0.960.180.91-0.440.91-0.780.190.63-0.070.840.630.960.830.70.71-0.970.110.870.950.520.630.650.65-0.4
0.48-0.440.75-0.440.75-0.180.62-0.060.030.28-0.120.470.450.630.09-0.640.310.30.66-0.040.63-0.05-0.050.0
0.720.480.36-0.080.36-0.76-0.270.7-0.080.750.970.770.430.260.86-0.62-0.120.750.510.760.65-0.051.0-0.56
0.720.480.36-0.080.36-0.76-0.270.7-0.080.750.970.770.430.260.86-0.62-0.120.750.510.760.65-0.051.0-0.56
-0.38-0.17-0.250.42-0.240.530.21-0.60.06-0.65-0.43-0.38-0.3-0.26-0.740.460.03-0.41-0.35-0.8-0.40.0-0.56-0.56
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Precision BioSciences has a Current Valuation of (14.68 Million). This is 100.1% lower than that of the Biotechnology sector and 100.32% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.09% higher than that of the company.

Precision Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precision BioSciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precision BioSciences could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics of similar companies.
Precision BioSciences is currently under evaluation in current valuation category among related companies.

Precision Fundamentals

About Precision BioSciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Precision BioSciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precision BioSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precision BioSciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Precision Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.

Pair Trading with Precision BioSciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precision BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Precision BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precision BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precision BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precision BioSciences to buy it.
The correlation of Precision BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precision BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precision BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precision BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Precision BioSciences Piotroski F Score and Precision BioSciences Altman Z Score analysis.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Precision Stock analysis

When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(25.76)
Revenue Per Share
13.887
Quarterly Revenue Growth
0.782
Return On Assets
(0.23)
Return On Equity
(1.54)
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.